SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001415889-11-001072
Filing Date
2011-10-03
Accepted
2011-10-03 17:19:02
Documents
1
Period of Report
2011-09-08
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 fluoropharma8ksept302011.htm 8-K 26637
  Complete submission text file 0001415889-11-001072.txt   27891
Mailing Address 500 BOYLSTON STREET SUITE 1600 BOSTON MA 02116
Business Address 500 BOYLSTON STREET SUITE 1600 BOSTON MA 02116 (617) 482-2333 X122
FLUOROPHARMA MEDICAL, INC. (Filer) CIK: 0001402785 (see all company filings)

IRS No.: 208325616 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-147193 | Film No.: 111121002
SIC: 4950 Sanitary Services